Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Effects on Mood and Behavior - Expectancy
NCT07061886Phase 1Completed
- Sponsor
- University of Chicago
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Lysergide (4 arms), sponsored by University of Chicago. Primary endpoints: Visual Analog Scale at 4 hours, Addiction Research Center Inventory at 4 hours and 3 more. Started Jun 2025; status: completed.
02
Drugs
Lysergide
Beyond the preview
Go deeper on NCT07061886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07061886.